Dixon Hughes Goodman Wealth Advisors’s bluebird bio BLUE Stock Holding History

Dixon Hughes Goodman Wealth Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$4K	Buy	+45	New	+$5.94K	﹤0.01%	629

Other funds holding BLUE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Dixon Hughes Goodman Wealth Advisors's BLUE Position: Q1 2022 in Review

Dixon Hughes Goodman Wealth Advisors opened a new position in bluebird bio (BLUE) in Q1 2022: 45 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #629 among its holdings.

174 funds tracked by Wall St. Rank hold BLUE as of Q1 2022.

Dixon Hughes Goodman Wealth Advisors held 45 shares of bluebird bio worth $4K as of Q1 2022.
bluebird bio was a new Dixon Hughes Goodman Wealth Advisors position in Q1 2022.
bluebird bio made up ﹤0.01% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #629 holding.
174 funds tracked by Wall St. Rank held bluebird bio as of Q1 2022.

Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.